DDMP and selective folinic acid protection in the treatment of malignant disease: a further report.
D001853:Bone Marrow / Q000187:drug effects; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D011739:Pyrimethamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012075:Remission, Spontaneous
C006308:metoprine; D002955:Leucovorin; D011739:Pyrimethamine